CE marked Real-time PCR for the detection and characterization of 2019-nCoV (later renamed SARS-CoV-2 by WHO) in the fight against COVID-19. The assay is compatible with a wide number of Extraction systems and real-time PCR platforms. The E-gene and orf1ab are detected in two separate ready to use mastermixes which each include an internal control.